1. 3300 A phase 1b/2 study of ribociclib (LEE011; CDK4/6 inhibitor) in combination with binimetinib (MEK162; MEK inhibitor) in patients with NRAS-mutant melanoma. (September 2015) Authors: Van Herpen, C.; Postow, M.A.; Carlino, M.S.; Kalkavan, H.; Weise, A.; Amaria, R.N.; Vos, F. De; Carvajal, R.D.; Matano, A.; Bhansali, S.; Lam, L.; Yerramilli-Rao, P.; Sosman, J.A. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S663 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 3302 Safety and Activity of Combined Radiotherapy (RT) and Anti-PD-1 Antibodies (PD-1) in Patients (pts) with Metastatic Melanoma. (September 2015) Authors: Liniker, E.; Kong, B.; Menzies, A.M.; Cooper, A.; Ramanujam, S.; Lo, S.; Kefford, R.F.; Fogarty, G.B.; Guminski, A.; Wang, T.W.; Carlino, M.S.; Hong, A.; Long, G.V. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S664 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. 3303 Efficacy and safety in key patient subgroups of nivolumab (NIVO) alone or combined with ipilimumab (IPI) versus IPI alone in treatment-naïve patients with advanced melanoma (MEL) (CheckMate 067). (September 2015) Authors: Larkin, J.; Chiarion-Sileni, V.; Gonzalez, R.; Grob, J.J.; Cowey, C.L.; Lao, C.D.; Wagstaff, J.; Hogg, D.; Hill, A.; Carlino, M.S.; Wolter, P.; Lebbé, C.; Schachter, J.; Thomas, L.; Hassel, J.C.; Lorigan, P.; Walker, D.; Jiang, J.; Hodi, F.S.; Wolchok, J.D. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S664 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. 3305 PD1 inhibition-induced changes in melanoma and its associated immune infiltrate. Issue 3 (September 2015) Authors: Vilain, R.E.; Kakavand, H.; Menzies, A.M.; Madore, J.; Wilmott, J.; Dobney, R.; Jakrot, V.; Cooper, A.J.; Kong, B.; Lo, S.; Liniker, E.; Saw, R.P.; Thompson, J.F.; Kefford, R.; Carlino, M.S.; Long, G.V.; Scolyer, R.A. Journal: European journal of cancer Issue: Volume 51:Issue 3(2015:Feb.) Page Start: S666 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. 76P Safety profile of adjuvant pembrolizumab (pembro) in melanoma, non-small cell lung cancer (NSCLC), and renal cell carcinoma (RCC): Pooled analysis of phase III clinical trials. (December 2022) Authors: Luke, J.J.; Long, G.V.; Robert, C.; Carlino, M.S.; Choueiri, T.K.; Haas, N.B.; O'Brien, M.E.R.; Paz-Ares, L.; Peters, S.; Powles, T.B.; Leiby, M.A.; Lin, J.; Zhao, Y.; Krepler, C.; Perini, R.F.; Pietanza, M.C.; Samkari, A.; Gruber, T.; Ibrahim, N.; Eggermont, A.M.M. Journal: Immuno-oncology technology Issue: Volume 16(2022)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Impact of baseline serum lactate dehydrogenase concentration on the efficacy of pembrolizumab and ipilimumab in patients with advanced melanoma: data from KEYNOTE-006. (February 2017) Authors: Long, G.V.; Blank, C.; Ribas, A.; Mortier, L.; Carlino, M.S.; Lotem, M.; Lorigan, P.; Neyns, B.; Petrella, T.M.; Puzanov, I.; Richtig, E.; O'Day, S.J.; Masucci, G.; Lebbe, C.; Steven, N.; Lutzky, J.; Hille, D.; Ebbinghaus, S.; Ibrahim, N.; McNeil, C. Journal: European journal of cancer Issue: Volume 72(2017)Supplement 1 Page Start: S122 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. PO-1413 Melanoma brain metastasis: The outcome of WBRT in the era of effective systemic therapy. (August 2021) Authors: Waldstein, C.; Wang, W.; Wang, W.; Lo, S.; Shivalingam, B.; Fogarty, G.B.; Carlino, M.S.; Menzies, A.M.; Long, G.V.; Hong, A. Journal: Radiotherapy and oncology Issue: Volume 161(2021)supplement Page Start: S1161 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗